[After the ALLHAT trial, what do we know about treatment for hypertension that we did not know before?].

Suppr

超能文献

作者信息

González-Juanatey José Ramón

机构信息

Servicio de Cardiología y Unidad Coronaria. Hospital Clínico Universitario. Santiago de Compostela. A Coruña. España.

出版信息

Rev Esp Cardiol. 2003 Jul;56(7):642-8.

PMID:12855144

Abstract

摘要

相似文献

[After the ALLHAT trial, what do we know about treatment for hypertension that we did not know before?].

Rev Esp Cardiol. 2003 Jul;56(7):642-8.

A family physician questions the conclusions from ALLHAT.

Am J Hypertens. 2004 Apr;17(4):361-5. doi: 10.1016/j.amjhyper.2003.11.011.

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) Trial: focus on the diabetic patient.

Curr Hypertens Rep. 2004 Jun;6(3):212-4.

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALL predictable, and no big surprise out of a HAT?

J Hum Hypertens. 2003 Jun;17(6):367-72. doi: 10.1038/sj.jhh.1001556.

LIFE and SCOPE: what guidance do they offer alongside ALLHAT and ANBP2?

J Hum Hypertens. 2004 May;18(5):295-300. doi: 10.1038/sj.jhh.1001675.

ALLHAT: a saga of missed opportunities.

J Hum Hypertens. 2003 Jun;17(6):373-7. doi: 10.1038/sj.jhh.1001564.

The design of ALLHAT may have biased the study's outcome in favor of the diuretic cohort.

Nat Clin Pract Nephrol. 2007 Feb;3(2):60-1. doi: 10.1038/ncpneph0391.

ALLHAT in perspective: implications to clinical practice and clinical trials.

Med J Malaysia. 2005 Jun;60(2):239-45.

A comparison between persistence to therapy in ALLHAT and in everyday clinical practice: a generalizability issue.

Can J Cardiol. 2004 Mar 15;20(4):417-21.

ALLHAT: definitive answers or continuing uncertainty?

J Renin Angiotensin Aldosterone Syst. 2003 Mar;4(1):3-5. doi: 10.3317/jraas.2003.004.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验